Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$8.94 - $18.35 $33,650 - $69,069
3,764 Added 28.48%
16,980 $311,000
Q1 2022

May 10, 2022

SELL
$5.62 - $12.37 $53,760 - $118,331
-9,566 Reduced 41.99%
13,216 $79,000
Q4 2021

Feb 10, 2022

BUY
$10.65 - $18.61 $121,314 - $211,986
11,391 Added 100.0%
22,782 $279,000
Q2 2021

Aug 11, 2021

BUY
$28.0 - $28.0 $318,948 - $318,948
11,391 New
11,391 $225,000

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $178M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.